Precigen (PGEN) EBT Margin (2012 - 2026)

Precigen's (PGEN) quarterly EBT Margin came in at 34.1% in Q1 2026, up 400415.0% year-on-year from N/an in Q1 2025, and up 88.59% on a QoQ basis from 298.79% in Q4 2025.

Precigen (PGEN) EBT Margin (2012 - 2026) Analysis & Trends

Precigen (PGEN) has 15 years of EBT Margin data on file, last reported at 34.1% in Q1 2026.

  • On a quarterly basis, EBT Margin rose 400415.0% year-over-year to 34.1% in Q1 2026; TTM through Mar 2026 was 622.44%, a 213307.0% increase from a year earlier, with the FY2025 full-year figure at 2588.18%, up 67368.0% from the prior year.
  • EBT Margin for Q1 2026 stood at 34.1%, up from 298.79% in the prior quarter.
  • Over the last five years, EBT Margin for PGEN reached as high as 152.41% in Q4 2022 and fell as low as 2396600.0% in Q3 2024.
  • Historically, EBT Margin has averaged 276020.43% across 5 years, with a median of 1692.62% in 2023.
  • Across the five-year window, EBT Margin tumbled 198004739 bps in 2023 and surged 238106454 bps in 2025, its largest moves.
  • Year by year, EBT Margin stood at 152.41% in 2022, then slumped by 1884 bps to 2718.89% in 2023, then jumped by 80 bps to 536.96% in 2024, then surged by 44 bps to 298.79% in 2025, then soared by 89 bps to 34.1% in 2026.
  • Per Business Quant data, the three most recent EBT Margin figures were 34.1% in Q1 2026, 298.79% in Q4 2025, and 15535.46% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 17.13%
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 41.95%
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 23.05%
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 34.77%
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Precigen 1.96 Bn 1.96 Bn 20.69 Mn -34.10%

Historic Data

Download Data
DateValue
Mar 31, 2026 -34.10%
Dec 31, 2025 -298.79%
Sep 30, 2025 -15,535.46%
Jun 30, 2025 -3,410.88%
Mar 31, 2025 -4,038.26%
Dec 31, 2024 -536.96%
Sep 30, 2024 -2,396,600.00%
Jun 30, 2024 -8,435.29%
Mar 31, 2024 -2,231.64%
Dec 31, 2023 -2,718.89%
Sep 30, 2023 -1,980,100.00%
Jun 30, 2023 -1,153.59%
Dec 31, 2022 152.41%
Sep 30, 2022 -52.61%
Jun 30, 2022 -898.25%
Mar 31, 2022 -434.54%
Dec 31, 2021 264.81%
Sep 30, 2021 -791.48%
Jun 30, 2021 -812.56%
Mar 31, 2021 -89.33%